The price of KDLY is predicted to go up -42.01%, based on the high correlation periods with ATNF. The similarity of these two price pattern on the periods is 98.24%.

KDLY

ATNF

Down: -42.01%Similarity: 98.24%

KDLY Revenue Forecast

KDLY EPS Forecast

KDLY FAQs

What is bull’s view on KDLY?

KDLY stock has recently shown positive momentum, trading at $1.97 with a 13.8% pre-market gain, driven by investor optimism around its plant-based treatment focus and strategic positioning in the medical cannabis sector. Bulls view KDLY as undervalued, with potential upside if it continues to capitalize on the growing demand for therapeutic cannabis, supported by its advocacy for medical integrity and patient-centric care. A near-term target of $2.50 is plausible if the company sustains its operational improvements and market expansion.

What is bear's view on KDLY?

KDLY stock closed at $1.30 on January 31, 2025, with a slight decline of 0.76% during regular trading. Bears argue that the stock faces challenges due to its reliance on the medical cannabis market, which is under pressure from the growing adult-use market, potentially reducing its long-term growth prospects. Additionally, the stock's recent pre-market drop of 2.19% reflects weak sentiment and limited investor confidence.